British association of dermatologists' guidelines for the management of lichen sclerosus 2010

British Journal of Dermatology

Volumn 163, Issue 4, 2010, Pages 672-682

  Neill, S M ^a   Lewis, F M ^b   Tatnall, F M ^c   Cox, N H ^d  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b FRIMLEY PARK HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^c WATFORD GENERAL HOSPITAL   (United Kingdom)

^d UNIVERSITY OF CUMBRIA   (United Kingdom)

Author keywords

guideline; lichen sclerosus; management

Indexed keywords

4 AMINOBENZOATE POTASSIUM; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTIMALARIAL AGENT; ANTIPRURITIC AGENT; CALCINEURIN INHIBITOR; CALCITRIOL; CORTICOSTEROID; CYCLOSPORIN A; HYDROXYUREA; METHOTREXATE; OXATOMIDE; RETINOID; STANOZOLOL;

CLINICAL FEATURE; CRYOTHERAPY; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; LICHEN SCLEROSUS ET ATROPHICUS; MEDICAL SOCIETY; PHOTODYNAMIC THERAPY; PHOTOTHERAPY; PRIORITY JOURNAL; PSYCHOSEXUAL DISORDER; REVIEW; SCAR FORMATION; SKIN BIOPSY; SQUAMOUS CELL CARCINOMA;

ADULT; CHILD; EVIDENCE-BASED MEDICINE; FEMALE; GENITAL DISEASES, FEMALE; GENITAL DISEASES, MALE; HUMANS; LICHEN SCLEROSUS ET ATROPHICUS; LONG-TERM CARE; MALE; TESTOSTERONE;

EID: 77957037536     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09997.x     Document Type: Review

References (116)

1. Griffiths CEM. The British Association of Dermatologists guidelines for the management of skin disease. Br J Dermatol 1999 141 : 396 397.
2. Cox NH, Williams HC. The British Association of Dermatologists Therapeutic Guidelines: can we AGREE? Br J Dermatol 2003 148 : 621 625.
3. Bell HK, Ormerod AD. Writing a British Association of Dermatologists clinical guideline: an update on the process and guidance for authors. Br J Dermatol 2009 160 : 725 728.
4. Appraisal of Guidelines Research and Evaluation. AGREE Instrument 2004. Available at: http://www.agreecollaboration.org/instrument/ (last accessed 3 August 2010).
5. Dickie RJ, Horne CHW, Sutherland HW. Direct evidence of localised immunological damage in lichen sclerosus et atrophicus. J Clin Pathol 1982 35 : 1395 1399.
6. Carli P, Cattaneo A, Pimpenelli N et al. Immunohistochemical evidence of skin immune system involvement in vulvar lichen sclerosus et atrophicus. Dermatologica 1991 182 : 18 22.
7. Farrell AM, Marren P, Dean D, Wojnarowska F. Lichen sclerosus: evidence that immunological changes occur at all levels of the skin. Br J Dermatol 1999 140 : 1087 1092.
8. Cooper SM, Ali I, Baldo M, Wojnarowska F. The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case-control study. Arch Dermatol 2008 144 : 1432 1435.
9. Harrington CI, Dunsmore IR. An investigation into the incidence of autoimmune disorders in patients with lichen sclerosus et atrophicus. Br J Dermatol 1981 104 : 563 566.
10. Meyrick Thomas RH, Ridley CM, Black MM. The association of lichen sclerosus atrophicus and autoimmune related disease in males. Br J Dermatol 1983 109 : 661 664.
11. Marren P, Charnock FM, Bunce M et al. The associations between lichen sclerosus and antigens of the HLA system. Br J Dermatol 1995 132 : 197 203.
12. Azurdia RM, Luzzi GA, Byren L et al. Lichen sclerosus in adult men: a study of HLA associations and susceptibility to autoimmune disease. Br J Dermatol 1999 140 : 79 83.
13. Powell J, Wojnarowska F, Winsey S et al. Lichen sclerosus premenarche: autoimmunity and immunogenetics. Br J Dermatol 2000 142 : 481 484.
14. De Vito JR, Merogi AJ, Vo T et al. Role of Borrelia burgdorferi in the pathogenesis of morphoea/scleroderma and lichen sclerosus et atrophicus: a PCR study of thirty-five cases. J Cutan Pathol 1996 23 : 350 358.
15. Fujiwara H, Fujiwara K, Hashimoto K et al. Detection of Borrelia burgdorferi DNA (B. garinii or B. afzelii) in morphoea and lichen sclerosus et atrophicus tissue of German and Japanese but not of US patients. Arch Dermatol 1997 133 : 41 4.
16. Chan I, Oyama N, Neill SM et al. Characterization of IgG autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Clin Exp Dermatol 2004 29 : 499 504.
17. Wallace HJ. Lichen sclerosus et atrophicus. Trans St Johns Hosp Dermatol Soc 1971 57 : 9 30.
18. Powell J, Wojnarowska F. Childhood vulvar lichen sclerosus: the course after puberty. J Reprod Med 2002 47 : 706 709.
19. Lipscombe TK, Wayte J, Wojnarowska F et al. A study of clinical and aetiological factors and possible associations of lichen sclerosus in males. Australas J Dermatol 1997 38 : 132 136.
20. Meffert JJ, Davis BM, Grimwood RE. Lichen sclerosus. J Am Acad Dermatol 1995 32 : 393 412.
21. Powell JJ, Wojnarowska F. Lichen sclerosus. Lancet 1999 353 : 1777 1783.
22. Smith YR, Haefner HK. Vulvar lichen sclerosus: pathophysiology and treatment. Am J Clin Dermatol 2004 5 : 105 125.
23. Pugliese JM, Morey AF, Peterson AC. Lichen sclerosus: review of the literature and current recommendations for management. J Urol 2007 178 : 2268 2276.
24. Neill SM, Lewis FM, eds. Ridley's The Vulva. London : Wiley-Blackwell, 2009 115 123.
25. Handfield-Jones SE, Hinde FR, Kennedy CTC. Lichen sclerosus et atrophicus in children misdiagnosed as sexual abuse. BMJ 1987 294 : 1404 1405.
26. Warrington S, San Lazaro C. Lichen sclerosus and sexual abuse. Arch Dis Child 1996 75 : 512 516.
27. Aynaud O, Piron D, Casanova JM. Incidence of preputial lichen sclerosus in adults: histologic study of circumcision specimens. J Am Acad Dermatol 1999 41 : 923 926.
28. Liatsikos EN, Perimenis P, Dandinis K et al. Lichen sclerosus et atrophicus. Findings after complete circumcision. Scand J Urol Nephrol 1997 31 : 453 456.
29. Chalmers RJ, Burton PA, Bennett RF et al. Lichen sclerosus et atrophicus. A common and distinctive cause of phimosis in boys. Arch Dermatol 1984 120 : 1025 1027.
30. Meuli M, Briner J, Hanimann B. Lichen sclerosus et atrophicus causing phimosis in boys: a prospective study with 5-year follow up after complete circumcision. J Urol 1994 152 : 987 989.
31. Kiss A, Király L, Kutasy B, Merksz M. High incidence of balanitis xerotica obliterans in boys with phimosis: prospective 10-year study. Pediatr Dermatol 2005 22 : 305 308.
32. Christman MS, Chen JT, Holmes NM. Obstructive complications of lichen sclerosus. J Pediatr Urol 2009 5 : 165 169.
33. Madan V, Cox NH. Extensive bullous lichen sclerosus with scarring alopecia. Clin Exp Dermatol 2009 34 : 360 362.
34. Ballister I, Bañuls J, Pérez-Crespo M, Lucas A. Extragenital bullous lichen sclerosus atrophicus. Dermatol Online J 2009 15 : 6.
35. Criado PR, Lima FH, Miguel DS et al. Lichen sclerosus - a keratotic variant. J Eur Acad Dermatol Venereol 2002 16 : 504 505.
36. Birenbaum DZ, Young RC. High prevalence of thyroid disease in patients with lichen sclerosus. J Reprod Med 2007 52 : 28 30.
37. Yesudian PD, Mendelssohn S, O'Mahoney C. Herpes simplex superinfection simulating erosive lichen sclerosus. Br J Dermatol 2006 155 (Suppl. 1 28 (abstr WR, Norris HJ, Helwig EB. Relation of lichen sclerosus et atrophicus of the vulva to development of carcinoma. Obstet Gynecol 1975 45 : 369 377.
38. Leibowitch M, Neill S, Pelisse M, Moyal-Baracco M. The epithelial changes associated with squamous cell carcinoma of the vulva: a review of the clinical, histological and viral findings in 78 women. Br J Obstet Gynaecol 1990 97 : 1135 1139.
39. Walkden V, Chia Y, Wojnarowska F. The association of squamous cell carcinoma and lichen sclerosus; implications for follow up. J Obstet Gynaecol 1997 17 : 551 553.
40. Vilmer C, Cavelier-Balloy B, Nogues C et al. Analysis of alterations adjacent to invasive vulvar cancer and their relationship with the associated carcinoma: a study of 67 cases. Eur J Gynaecol Oncol 1998 19 : 25 31.
41. van Seters M, ten Kate FJ, van Beurden M et al. In the absence of (early) invasive carcinoma, vulvar intraepithelial neoplasia associated with lichen sclerosus is mainly of undifferentiated type: new insights in histology and aetiology. J Clin Pathol 2007 60 : 504 509.
42. Nasca MR, Innocenzi D, Micali G. Penile cancer among patients with genital lichen sclerosus. J Am Acad Dermatol 1999 41 : 911 914.
43. Depasquale I, Park AJ, Bracka A. The treatment of balanitis xerotica obliterans. BJU Int 2000 86 : 459 465.
44. Powell J, Robson A, Cranston D et al. High incidence of lichen sclerosus in patients with squamous cell carcinoma of the penis. Br J Dermatol 2001 145 : 85 9.
45. Barbagli G, Palminteri E, Mirri F et al. Penile carcinoma in patients with genital lichen sclerosus: a multicenter survey. J Urol 2006 175 : 1359 1363.
46. Cupp MR, Malek RS, Goellner JR et al. The detection of human papillomavirus deoxyribonucleic acid in intraepithelial, in situ, verrucous and invasive carcinoma of the penis. J Urol 1995 154 : 1024 1029.
47. Lau PW, Cook N, Andrews H et al. Detection of human papillomavirus types in balanitis xerotica obliterans and other penile conditions. Genitourin Med 1995 71 : 228 230.
48. Nasca MR, Innocenzi D, Micali G. Association of penile lichen sclerosus and oncogenic human papillomavirus. Int J Dermatol 2006 45 : 681 683.
49. Prowse DM, Ktori EN, Chandrasekaran D et al. Human papillomavirus- associated increase in p16INK4A expression in penile lichen sclerosus and squamous cell carcinoma. Br J Dermatol 2008 158 : 261 265.
50. Innocenzi D, Nasca MR, Skroza N et al. Penile lichen sclerosus: correlation between histopathologic features and risk of cancer. Acta Dermatovenerol Croat 2006 14 : 225 229.
51. Paniel BJ, Berville-Levy S, Moyal-Baracco M. La vulvopériné oplastie. J Gynécol Obstét Biol Reprod 1984 31 : 91 9.
52. Paniel BJ, Rouzier R. Surgical procedures in benign disease. In : Ridley's The Vulva (Neill SM, Lewis FM, eds). London : Wiley-Blackwell, 2009 236.
53. Dalziel K. Effect of lichen sclerosus on sexual function and parturition. J Reprod Med 1995 40 : 351 354.
54. Marin MG, King R, Dennerstein GJ, Sfameni S. Dyspareunia and vulval disease. J Reprod Med 1998 43 : 952 958.
55. Dalziel K, Millard PR, Wojnarowska F. The treatment of vulvar lichen sclerosus with a very potent topical corticosteroid (clobetasol propionate 0.05%) cream. Br J Dermatol 1991 124 : 461 464.
56. Lorenz B, Kaufman RH, Kutzner SK. Lichen sclerosus. Therapy with clobetasol propionate. J Reprod Med 1998 43 : 790 794.
57. Ayhan A, Guven S, Guvendag Guven ES et al. Topical testosterone versus clobetasol for vulvar lichen sclerosus. Int J Gynaecol Obstet 2007 96 : 117 121.
58. Lagos BR, Maibach HI. Frequency of application of topical corticosteroids: an overview. Br J Dermatol 1998 139 : 763 766.
59. Renaud-Vilmer C, Cavalier-Balloy B, Porcher R, Dubertret L. Vulvar lichen sclerosus. Arch Dermatol 2004 140 : 709 712.
60. Cooper SM, Gao XH, Powell J, Wojnarowska F. Does treatment of vulvar lichen sclerosus influence its prognosis? Arch Dermatol 2004 140 : 702 706.
61. Diakomanolis ES, Haidopoulos D, Syndos M et al. Vulvar lichen sclerosus in postmenopausal women: a comparative study for treating advanced disease with clobetasol propionate 0.05%. Eur J Gynaecol Oncol 2002 23 : 519 522.
62. Cattaneo A, de Magnis A, Botti E et al. Topical mometasone furoate for vulvar lichen sclerosus. J Reprod Med 2003 48 : 444 448.
63. Simonart T, Lahaye M, Simonart JM. Vulvar lichen sclerosus: effect of maintenance treatment with a moisturizer on the course of the disease. Menopause 2008 15 : 74 7.
64. Dahlman-Ghozlan K, von Hedblad MA, Krogh G. Penile lichen sclerosus treated with clobetasol dipropionate 0.05% cream: a retrospective clinical and histopathological study. J Am Acad Dermatol 1999 40 : 451 457.
65. Riddell L, Edwards A, Sherrard J. Clinical features of lichen sclerosus in men attending a department of genitourinary medicine. Sex Transm Infect 2000 76 : 311 313.
66. Powell J, Wojnarowska F. Childhood vulvar lichen sclerosus: an increasingly common problem. J Am Acad Dermatol 2001 44 : 803 806.
67. Fischer G, Rogers M. Treatment of childhood vulval lichen sclerosus with potent topical corticosteroid. Pediatr Dermatol 1997 14 : 235 238.
68. Garzon MC, Paller AS. Ultrapotent topical corticosteroid treatment of childhood lichen sclerosus. Arch Dermatol 1999 135 : 525 528.
69. Yang SSD, Tsai YC, Wu CC et al. Highly potent and moderately potent topical steroids are effective in treating phimosis: a prospective randomized study. J Urol 2005 173 : 1361 1363.
70. Kiss A, Csontai A, Nyirady P et al. The response of balanitis xerotica obliterans to local steroid application compared with placebo in children. J Urol 2001 165 : 219 220.
71. Jørgensen ET, Svensson A. The treatment of phimosis in boys, with a potent topical steroid (clobetasol propionate 0.05%) cream. Acta Derm Venereol (Stockh) 1993 73 : 55 6.
72. Lindhagen T. Topical clobetasol propionate compared with placebo in the treatment of unretractable foreskin. Eur J Surg 1996 162 : 969 972.
73. Ghysel C, Vander Eeckt K, Bogaert GA. Long-term efficiency of skin stretching and a topical corticoid cream application for unretractable foreskin and phimosis in prepubertal boys. Urol Int 2009 82 : 81 8.
74. Sideri M, Origoni M, Spinaci L, Ferrari A. Topical testosterone in the treatment of vulvar lichen sclerosus. Int J Gynaecol Obstet 1994 46 : 53 6.
75. Cattaneo A, Carli P, De Marco A et al. Testosterone maintenance therapy. Effects on vulval lichen sclerosus treated with clobetasol propionate. J Reprod Med 1996 41 : 99 102.
76. Bornstein J, Heifetz S, Kellner Y et al. Clobetasol dipropionate 0.05% versus testosterone 2% topical application for severe vulvar lichen sclerosus. Am J Obstet Gynecol 1998 178 : 80 4.
77. Jasionowski EA, Jasionowski PA. Further observations of the effect of topical progesterone on vulvar disease. Am J Obstet Gynecol 1979 134 : 565 567.
78. August PJ, Milward TM. Cryosurgery in the treatment of lichen sclerosus et atrophicus of the vulva. Br J Dermatol 1980 103 : 667 670.
79. Hillemans P, Untch M, Prove F et al. Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid. Obstet Gynecol 1999 93 : 71 4.
80. Zawislak AA, McCluggage WG, Donnelly RF et al. Response of vulval lichen sclerosus and squamous hyperplasia to photodynamic treatment using sustained topical delivery of aminolevulinic acid from a novel bioadhesive patch system. Photodermatol Photoimmunol Photomed 2009 25 : 111 113.
81. Beattie PE, Dawe RS, Ferguson J, Ibbotson SH. UVA1 phototherapy for genital lichen sclerosus. Clin Exp Dermatol 2006 31 : 343 347.
82. Kartamaa M, Reitamo S. Treatment of lichen sclerosus with carbon dioxide laser vaporization. Br J Dermatol 1997 136 : 356 359.
83. Li C, Bian D, Chen W et al. Focussed ultrasound therapy of vulvar dystrophies: a feasibility study. Obstet Gynecol 2004 104 : 915 921.
84. Kulkarni S, Barbagli G, Kirpekar D et al. Lichen sclerosus of the male genitalia and urethra: surgical options and results in a multicenter international experience with 215 patients. Eur Urol 2009 55 : 945 954.
85. Levine LA, Strom KH, Lux MM. Buccal mucosa graft urethroplasty for anterior urethral stricture repair: evaluation of the impact of stricture location and lichen sclerosus on surgical outcome. J Urol 2007 178 : 2011 2015.
86. Hrebinko RL. Circumferential laser vaporization for severe meatal stenosis secondary to balanitis xerotica obliterans. J Urol 1996 156 : 1735 1736.
87. Windahl T. Is carbon dioxide laser treatment of lichen sclerosus effective in the long run? Scand J Urol Nephrol 2006 40 : 208 211.
88. Klein LE, Cohen SR, Weinstein M. Bullous lichen sclerosus et atrophicus: treatment by tangential excision. J Am Acad Dermatol 1984 10 : 346 350.
89. Breuckmann F, Gambichler T, Altmeyer P, Kreuter A. UVA/UVA1 phototherapy and PUVA photochemotherapy in connective tissue diseases and related disorders: a research based review. BMC Dermatol 2004 4 : 11.
90. Colbert RL, Chiang MP, Carlin CS, Fleming M. Progressive extragenital lichen sclerosus successfully treated with narrowband UV-B phototherapy. Arch Dermatol 2007 143 : 19 20.
91. Valdivielso-Ramos M, Bueno C, Hernanz JM. Significant improvement in extensive lichen sclerosus with tacrolimus ointment and PUVA. Am J Clin Dermatol 2008 9 : 175 179.
92. Kroft EB, Berkhof NJ, van de Kerkhof PC et al. Ultraviolet A phototherapy for sclerotic skin diseases: a systematic review. J Am Acad Dermatol 2008 59 : 1017 1030.
93. Rombold S, Lobisch K, Katzer K et al. Efficacy of UVA1 phototherapy in 230 patients with various skin diseases. Photodermatol Photoimmunol Photomed 2008 24 : 19 23.
94. Passeron T, Lacour JP, Ortonne JP. Comparative treatment of extra-genital lichen sclerosus with methyl amino laevulinic acid pulsed dye laser mediated photodynamic therapy or pulsed dye laser alone. Dermatol Surg 2009 35 : 878 880.
95. Goldstein AT, Marinoff SC, Christopher K. Pimecrolimus for the treatment of vulvar lichen sclerosus: a report of 4 cases. J Reprod Med 2004 49 : 778 780.
96. Luesley DM, Downey GP. Topical tacrolimus in the management of lichen sclerosus. Br J Obstet Gynaecol 2006 113 : 823 824.
97. Nissi R, Eriksen H, Risteli J, Niemimaa M. Pimecrolimus cream 1% in the management of lichen sclerosus. Gynecol Obstet Invest 2007 127 : 808 816.
98. Virgili A, Lauriola MM, Mantovani L, Corrazza M. Vulvar lichen sclerosus: 11 women treated with tacrolimus 0.1% ointment. Acta Derm Venereol 2007 87 : 69 72.
99. Hengge UR, Krause W, Hofmann H et al. Multicentre, phase II trial on the safety of topical tacrolimus ointment for the treatment of lichen sclerosus. Br J Dermatol 2006 155 : 1021 1028.
100. Boms S, Gambichler T, Frietag M et al. Pimecrolimus 1% cream for anogenital lichen sclerosus in childhood. BMC Dermatol 2004 4 : 14.
101. Bunker CB, Neill SM, Staughton RCD. Topical tacrolimus, genital lichen sclerosus and risk of squamous cell carcinoma. Arch Dermatol 2004 140 : 1169.
102. Ormerod AD. Topical tacrolimus and pimecrolimus and the risk of cancer: how much cause for concern? Br J Dermatol 2005 153 : 701 705.
103. Becker JC, Houben R, Vetter CS, Brocker EB. The carcinogenic potential of tacrolimus ointment beyond immune suppression: a hypothesis creating case report. BMC Cancer 2006 6 : 7.
104. Edey K, Bisson D, Kennedy C. Topical tacrolimus in the management of lichen sclerosus. Br J Obstet Gynaecol 2006 113 : 1482.
105. Fischer G, Bradford J. Topical immunosuppressants, genital lichen sclerosus and the risk of squamous cell carcinoma: a case report. J Reprod Med 2007 52 : 329 331.
106. Carli P, Cattaneo A, Taddei G, Gianotti B. Topical cyclosporine in the treatment of vulvar lichen sclerosus: clinical histologic and immunohistochemical findings. Arch Dermatol 1992 128 : 1279 1280.
107. Bulbul Baskan E, Turan H, Tunali S et al. Open-label trial of cyclosporine for vulvar lichen sclerosus. J Am Acad Dermatol 2007 57 : 276 278.
108. Nayeemuddin F, Yates VM. Lichen sclerosus et atrophicus responding to methotrexate. Clin Exp Dermatol 2008 33 : 651 652.
109. Tomson N, Sterling JC. Hydroxycarbamide: a treatment for lichen sclerosus? Br J Dermatol 2007 157 : 622.
110. Kreuter A, Tigges C, Gaifullina R et al. Pulsed high-dose corticosteroids combined with low-dose methotrexate treatment in patients with refractory generalized extragenital lichen sclerosus. Arch Dermatol 2009 145 : 1303 1308.
111. Mork N-J, Jensen P, Hoel PS. Vulval lichen sclerosus treated with etretinate (Tigason). Acta Derm Venereol (Stockh) 1986 66 : 363 365.
112. Bousema MT, Romppanen U, Geiger J-M et al. Acitretin in the treatment of lichen sclerosus et atrophicus of the vulva: a double blind placebo controlled study. J Am Acad Dermatol 1994 30 : 225 231.
113. Virgili A, Corazza M, Bianchi A et al. Open study of topical 0.025% tretinoin in the treatment of vulval lichen sclerosus. One year of therapy. J Reprod Med 1995 40 : 614 618.
114. Penneys NS. Treatment of lichen sclerosus with potassium para-aminobenzoate. J Am Acad Dermatol 1984 10 : 1039 1042.
115. Balasubramaniam P, Lewis FM. Long-term follow-up of patients with lichen sclerosus: does it really happen? J Obstet Gynaecol 2007 27 : 282.
116. Jones RW, Curry J, Neill S, MacLean AB. Guidelines for the follow-up of women with vulvar lichen sclerosus in specialist clinics. Am J Obstet Gynecol 2008 198 : 496. e1 3.